TAG and IMPAACT4TB project partners release several materials to explain how the identification of nitrosamines in rifampicin and rifapentine may affect the safety and supply of TB medicines, and what this may mean for TB programs and patients.

The accountability report of TB-affected communities and civil society: Priorities to close the deadly divide

The Indian Patent Office takes a laudable step that will pave the way for generic manufacturing of a key TB drug.

Global TB community calls on world leaders to increase political and financial commitments to develop and roll out new TB vaccines as a central part of the global TB response.

On World TB Day 2023, ECDC and WHO/Europe issue a sobering warning that, despite having the tools to end TB, the European Region remains a long way from meeting its End TB Strategy targets.

WHO announces the expanded scope of the WHO Director-General’s Flagship Initiative on TB over the period 2023-2027 to support fast-tracking progress towards ending TB and achieving Universal Health Coverage by 2030.

The Fast Track the Cure campaign demands universal access to six-month drug-resistant TB cure by 2024.

Treatment Action Group and the 1/4/6x24 Campaign Coalition launch the 1/4/6x24 World TB Day Toolkit to support advocacy the week of World TB Day for access to shorter, safer regimens for TB prevention and treatment.

The Coordination Hub launches the World TB Day Advocacy Toolkit to support the kick-start of advocacy at the national level in the lead up to the 2023 UN High-Level Meeting on TB.

The World Health Organization launches the World TB Day Advocacy & Communications Toolkit, featuring key messages and calls to action, as well as promotional posters, tiles and infographics.